Dr. Mahler is currently CEO and Board Member at ten23 health AG, the human-centric and sustainable pharmaceutical development partner. In addition, he is Professor at the Universities of Basel and Frankfurt/Main serves as Scientific Expert at the European Pharmacopeia/ European Directorate for Quality of Medicines & Healthcare (EDQM), and as Editor for various scientific journals. He previously worked in various roles at Lonza AG (starting and leading the Drug Product Business), at F.Hoffmann-La Roche AG (leading Pharmaceutical Development & Supplies) and Merck KGaA (various functions). Hanns-Christian studied Pharmacy, holds a PhD and did his Habilitation in Pharmacy.